These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12111125)

  • 1. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
    Reubi C; Gugger M; Waser B
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
    Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
    Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A; Waser B; Reubi JC
    Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R; Reubi JC
    Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.
    Reubi JC; Waser B
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):781-93. PubMed ID: 12707737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
    Körner M; Waser B; Reubi JC
    Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
    Reubi JC; Gugger M; Waser B; Schaer JC
    Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
    Gugger M; Reubi JC
    Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
    Körner M; Reubi JC
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide receptor expression in GEP-NET.
    Reubi JC
    Virchows Arch; 2007 Aug; 451 Suppl 1():S47-50. PubMed ID: 17684767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment.
    Reubi JC
    Neuroendocrinology; 2004; 80 Suppl 1():51-6. PubMed ID: 15477718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early over-expression of GRP receptors in prostatic carcinogenesis.
    Körner M; Waser B; Rehmann R; Reubi JC
    Prostate; 2014 Feb; 74(2):217-24. PubMed ID: 24150752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
    Mihai R; Stevens J; McKinney C; Ibrahim NB
    Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.